83 FR 14503 - Mehdi Nikparvarfard, M.D.; Decision and Order

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 83, Issue 65 (April 4, 2018)

Page Range		14503-14504
FR Document		2018-06870
Federal Register, Volume 83 Issue 65 (Wednesday, April 4, 2018)
[Federal Register Volume 83, Number 65 (Wednesday, April 4, 2018)]
[Notices]
[Pages 14503-14504]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-06870]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Mehdi Nikparvarfard, M.D.; Decision and Order

    On October 20, 2017, the Acting Assistant Administrator, Diversion 
Control Division, Drug Enforcement Administration (DEA), issued an 
Order to Show Cause to Mehdi Nikparvarfard, M.D. (Registrant), of 
Philadelphia, Pennsylvania. The Show Cause Order proposed the 
revocation of Registrant's Certificate of Registration No. BN8871231 on 
the ground that he has ``no state authority to handle controlled 
substances.'' Order to Show Cause, Government Exhibit (GX) 2, at 1 
(citing 21 U.S.C. 824(a)(3)). For the same reason, the Order also 
proposed the denial of any of Registrant's ``applications for renewal 
or modification of such registration and any applications for any other 
DEA registrations.'' Id.
    With respect to the Agency's jurisdiction, the Show Cause Order 
alleged that Registrant is registered as a practitioner in schedules II 
through V, pursuant to DEA Certificate of Registration No. BN8871231, 
at the address of Advanced Urgent Care, 5058 City Ave., Philadelphia, 
Pennsylvania. Id. The Order also alleged that this registration does 
not expire until October 31, 2019. Id.
    As substantive grounds for the proceeding, the Show Cause Order 
alleged that on September 15, 2017, the Commonwealth of Pennsylvania 
State Board of Medicine ``issued an Order of Temporary Suspension and 
Notice of Hearing in which it suspended [Registrant's] license to 
practice'' medicine. Id. The Order alleged that, as a result, he is 
``currently without authority to practice medicine or handle controlled 
substances in the Commonwealth of Pennsylvania, the [S]tate in which 
[he is] registered with the DEA.'' Id. at 1-2. Based on his ``lack of 
authority to handle controlled substances in the Commonwealth of 
Pennsylvania,'' the Order asserted that ``DEA must revoke'' his 
registration. Id. at 2 (citing 21 U.S.C. 824(a)(3); 21 CFR 1301.37(b)).
    The Show Cause Order notified Registrant of his right to request a 
hearing on the allegations or to submit a written statement in lieu of 
a hearing, the procedure for electing either option, and the 
consequence for failing to elect either option. Id. (citing 21 CFR 
1301.43). The Show Cause Order also notified Registrant of his right to 
submit a corrective action plan. Id. at 2-3 (citing 21 U.S.C. 
824(c)(2)(C)).
    The Government states that on October 27, 2017, ``personnel from 
DEA's Philadelphia Field Division personally served the [Show Cause] 
Order on Registrant at the Philadelphia Federal Detention Center where 
he was incarcerated.'' Government's Request for Final Agency Action 
(RFFA), at 2 (citing GX 5). Specifically, a DEA Diversion Investigator 
from that Field Division states that she, along with a Task Force 
Officer, ``presented the [Order] to Dr. Nikparvar-Fard'' and that he 
``took the [Order].'' GX5, at 1.
    On December 21, 2018, the Government forwarded its Request for 
Final Agency Action and an evidentiary record to my Office. Therein, 
the Government represents that it has not received a hearing request 
and that Registrant ``has not otherwise corresponded or communicated 
with DEA regarding the Order served on him.'' RFFA, at 2. Based on the 
Government's representation and the record, I find that more than 30 
days have passed since the Order to Show Cause was served on 
Registrant, and he has neither requested a hearing nor submitted a 
written statement in lieu of a hearing. See 21 CFR 1301.43(d). 
Accordingly, I find that Registrant has waived his right to a hearing 
or to submit a written statement and issue this Decision and Order 
based on relevant evidence submitted by the Government. I make the 
following findings.

Findings of Fact

    Registrant is a physician who is registered as a practitioner in 
schedules II-V pursuant to Certificate of Registration No. BN8871231, 
at the registered address of Advanced Urgent Care, 5058 City Ave., 
Philadelphia, Pennsylvania. See GX 1 (DEA Certification of Registration 
Status), at 1. Although not alleged in the Show Cause Order, I also 
find that Registrant is the holder of DATA-Waiver Identification Number 
XN8871231, see id. at 1-2,\1\ which authorizes Registrant to dispense 
or prescribe schedule III-V narcotic controlled substances which ``have 
been approved by the Food and Drug Administration . . . specifically 
for use in maintenance or detoxification treatment'' for up to 275 
patients. 21 CFR 1301.28(a) & (b)(1)(iii). His registration does not 
expire until October 31, 2019. Id.
---------------------------------------------------------------------------

    \1\ The DEA Certification of Registration Status confirms that 
Registrant has DATA-Waiver Authority, but it does not include the 
identification number for that authority. However, I take official 
notice that the Agency's registration records show that Registrant's 
DATA-Waiver Identification Number is XN8871231. Under the 
Administrative Procedure Act (APA), an agency ``may take official 
notice of facts at any stage in a proceeding--even in the final 
decision.'' U.S. Dept. of Justice, Attorney General's Manual on the 
Administrative Procedure Act 80 (1947) (Wm. W. Gaunt & Sons, Inc., 
Reprint 1979). In accordance with the APA and DEA's regulations, 
Registrant is ``entitled on timely request to an opportunity to show 
to the contrary.'' 5 U.S.C. 556(e); see also 21 CFR 1316.59(e).
---------------------------------------------------------------------------

    The record also shows, and I so find, that on September 22, 2016, 
Registrant ``submitted a new online application for a DEA registration 
bearing an address of 721 Bethleh[e]m Pike, Montgomeryville,'' 
Pennsylvania, as a practitioner in schedules II-V. I find that this new 
application remains pending. See id. at 2.
    On September 15, 2017, the Commonwealth of Pennsylvania's State 
Board of Medicine issued an ``Order of Temporary Suspension and Notice 
Hearing'' to Registrant that ``TEMPORARILY SUSPENDED'' his ``license to 
practice as a medical

[[Page 14504]]

physician and surgeon'' in Pennsylvania. GX 3, at 1, 2. The Board also 
directed Registrant to ``surrender his wall certificate(s), biennial 
renewal certificate(s) and wallet card(s)'' to state authorities upon 
service of the Order. Id. at 2. On October 6, 2017, the Board issued an 
``Order Granting Continuance and Continuing Suspension'' stating that 
Registrant had ``agree[d] to toll the 180-day limit for the immediate 
and temporary suspension of [his] license . . . and [his] license shall 
remain SUSPENDED until a preliminary hearing is rescheduled or upon 
further order of the State Board of Medicine.'' GX 4, at 1. In light of 
the passage of time since the effective date of the Order, I have 
queried the Pennsylvania Medical Board's website regarding the status 
of Registrant's medical license, and I take official notice \2\ that 
Registrant's Pennsylvania medical license remains suspended as of the 
date of this decision. Based on the above, I find that Registrant does 
not currently have authority under the laws of Pennsylvania to dispense 
controlled substances.
---------------------------------------------------------------------------

    \2\ See supra footnote 1.
---------------------------------------------------------------------------

Discussion

    Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized 
to suspend or revoke a registration issued under section 823 of Title 
21, ``upon a finding that the registrant . . . has had his State 
license . . . suspended [or] revoked . . . by competent State authority 
and is no longer authorized by State law to engage in the . . . 
dispensing of controlled substances.'' With respect to a practitioner, 
DEA has long held that the possession of authority to dispense 
controlled substances under the laws of the State in which a 
practitioner engages in professional practice is a fundamental 
condition for obtaining and maintaining a registration. See, e.g., 
James L. Hooper, 76 FR 71371 (2011), pet. for rev. denied, 481 Fed. 
Appx. 826 (4th Cir. 2012); see also Frederick Marsh Blanton, 43 FR 
27616 (1978) (``State authorization to dispense or otherwise handle 
controlled substances is a prerequisite to the issuance and maintenance 
of a Federal controlled substances registration.'').
    This rule derives from the text of two provisions of the CSA. 
First, Congress defined ``the term `practitioner' [to] mean[] a . . . 
physician . . . or other person licensed, registered or otherwise 
permitted, by . . . the jurisdiction in which he practices . . . to 
distribute, dispense, [or] administer . . . a controlled substance in 
the course of professional practice.'' 21 U.S.C. 802(21). Second, in 
setting the requirements for obtaining a practitioner's registration, 
Congress directed that ``[t]he Attorney General shall register 
practitioners . . . if the applicant is authorized to dispense . . . 
controlled substances under the laws of the State in which [s]he 
practices.'' 21 U.S.C. 823(f). Because Congress has clearly mandated 
that a practitioner possess state authority in order to be deemed a 
practitioner under the Act, DEA has held repeatedly that revocation of 
a practitioner's registration is the appropriate sanction whenever he 
is no longer authorized to dispense controlled substances under the 
laws of the State in which he engages in professional practice. See, 
e.g., Calvin Ramsey, 76 FR 20034, 20036 (2011); Sheran Arden Yeates, 
M.D., 71 FR 39130, 39131 (2006); Dominick A. Ricci, 58 FR 51104, 51105 
(1993); Bobby Watts, 53 FR 11919, 11920 (1988); Blanton, 43 FR 27616 
(1978).
    Moreover, because ``the controlling question'' in a proceeding 
brought under 21 U.S.C. 824(a)(3) is whether the holder of a DEA 
registration ``is currently authorized to handle controlled substances 
in the [S]tate,'' Hooper, 76 FR at 71371 (quoting Anne Lazar Thorn, 62 
FR 12847, 12848 (1997)), the Agency has also long held that revocation 
is warranted even where a practitioner has lost his state authority by 
virtue of the State's use of summary process and the State has yet to 
provide a hearing to challenge the suspension. Bourne Pharmacy, 72 FR 
18273, 18274 (2007); Wingfield Drugs, 52 FR 27070, 27071 (1987). Thus, 
it is of no consequence that the Pennsylvania Medical Board has 
suspended Registrant's state license and that Registrant may prevail in 
a future state hearing. What is consequential is the fact that 
Registrant is not currently authorized to dispense controlled 
substances in Pennsylvania, the State in which he is registered. I will 
therefore revoke his DEA registration, deny any pending application to 
modify his registration, or any pending application for any other 
registration in Pennsylvania.

Order

    Pursuant to the authority vested in me by 21 U.S.C. 823(f) and 
824(a), as well as 28 CFR 0.100(b), I order that DEA Certificate of 
Registration No. BN8871231 and DATA-Waiver Identification Number 
XN8871231, issued to Mehdi Nikparvarfard, M.D., be, and it hereby is, 
revoked. I further order that any pending application of Mehdi 
Nikparvarfard to renew or modify the above registration, or any pending 
application for any other registration in the Commonwealth of 
Pennsylvania, be, and it hereby is, denied. This Order is effective 
immediately.\3\
---------------------------------------------------------------------------

    \3\ For the same reasons that led the Pennsylvania Board of 
Medicine to suspend Registrant's license, I find that the public 
interest necessitates that this Order be effective immediately. 21 
CFR 1316.67.

    Dated: March 26, 2018.
Robert W. Patterson,
Acting Administrator.
[FR Doc. 2018-06870 Filed 4-3-18; 8:45 am]
BILLING CODE 4410-09-P
Federal Register / Vol. 83, No. 65 / Wednesday, April 4, 2018 / Notices 14503

about the disposition of any firearm in any applications for any other DEA Government’s representation and the
the course of a criminal investigation. registrations.’’ Id. record, I find that more than 30 days
5. An estimate of the total number of With respect to the Agency’s have passed since the Order to Show
respondents and the amount of time jurisdiction, the Show Cause Order Cause was served on Registrant, and he
estimated for an average respondent to alleged that Registrant is registered as a has neither requested a hearing nor
respond: An estimated 9,056 practitioner in schedules II through V, submitted a written statement in lieu of
respondents will respond approximately pursuant to DEA Certificate of a hearing. See 21 CFR 1301.43(d).
1,269.59375 times, and it will take each Registration No. BN8871231, at the Accordingly, I find that Registrant has
respondent approximately 1.05 minutes address of Advanced Urgent Care, 5058 waived his right to a hearing or to
to complete each response. City Ave., Philadelphia, Pennsylvania. submit a written statement and issue
6. An estimate of the total public Id. The Order also alleged that this this Decision and Order based on
burden (in hours) associated with the registration does not expire until relevant evidence submitted by the
collection: The estimated annual public October 31, 2019. Id. Government. I make the following
As substantive grounds for the findings.
burden associated with this collection is
proceeding, the Show Cause Order
201,205 hours which is equal to 9,056 Findings of Fact
alleged that on September 15, 2017, the
(# of respondents) * 1,269.59375 (# of Registrant is a physician who is
Commonwealth of Pennsylvania State
responses per person) * .0175 (1.05 Board of Medicine ‘‘issued an Order of registered as a practitioner in schedules
minutes). Temporary Suspension and Notice of II–V pursuant to Certificate of
7. An Explanation of the Change in Hearing in which it suspended Registration No. BN8871231, at the
Estimates: The increase in total [Registrant’s] license to practice’’ registered address of Advanced Urgent
responses by 6,678, total respondents by medicine. Id. The Order alleged that, as Care, 5058 City Ave., Philadelphia,
1,523,647 and total burden hours by a result, he is ‘‘currently without Pennsylvania. See GX 1 (DEA
23,673, are due to a general increase in authority to practice medicine or handle Certification of Registration Status), at 1.
both the number of firearms controlled substances in the Although not alleged in the Show Cause
manufacturers that respond to this Commonwealth of Pennsylvania, the Order, I also find that Registrant is the
collection and the number of firearms [S]tate in which [he is] registered with holder of DATA-Waiver Identification
produced each year. the DEA.’’ Id. at 1–2. Based on his ‘‘lack Number XN8871231, see id. at 1–2,1
If additional information is required of authority to handle controlled which authorizes Registrant to dispense
contact: Melody Braswell, Department substances in the Commonwealth of or prescribe schedule III–V narcotic
Clearance Officer, United States Pennsylvania,’’ the Order asserted that controlled substances which ‘‘have been
Department of Justice, Justice ‘‘DEA must revoke’’ his registration. Id. approved by the Food and Drug
Management Division, Policy and at 2 (citing 21 U.S.C. 824(a)(3); 21 CFR Administration . . . specifically for use
Planning Staff, Two Constitution 1301.37(b)). in maintenance or detoxification
Square, 145 N Street NE, 3E.405A, The Show Cause Order notified treatment’’ for up to 275 patients. 21
Washington, DC 20530. Registrant of his right to request a CFR 1301.28(a) & (b)(1)(iii). His
Dated: March 29, 2018. hearing on the allegations or to submit registration does not expire until
Melody Braswell,
a written statement in lieu of a hearing, October 31, 2019. Id.
the procedure for electing either option, The record also shows, and I so find,
Department Clearance Officer for PRA, U.S.
and the consequence for failing to elect that on September 22, 2016, Registrant
Department of Justice.
either option. Id. (citing 21 CFR ‘‘submitted a new online application for
[FR Doc. 2018–06768 Filed 4–3–18; 8:45 am]
1301.43). The Show Cause Order also a DEA registration bearing an address of
BILLING CODE 4410–FY–P
notified Registrant of his right to submit 721 Bethleh[e]m Pike,
a corrective action plan. Id. at 2–3 Montgomeryville,’’ Pennsylvania, as a
(citing 21 U.S.C. 824(c)(2)(C)). practitioner in schedules II–V. I find
DEPARTMENT OF JUSTICE The Government states that on that this new application remains
Drug Enforcement Administration October 27, 2017, ‘‘personnel from pending. See id. at 2.
DEA’s Philadelphia Field Division On September 15, 2017, the
Mehdi Nikparvarfard, M.D.; Decision personally served the [Show Cause] Commonwealth of Pennsylvania’s State
and Order Order on Registrant at the Philadelphia Board of Medicine issued an ‘‘Order of
Federal Detention Center where he was Temporary Suspension and Notice
On October 20, 2017, the Acting incarcerated.’’ Government’s Request for Hearing’’ to Registrant that
Assistant Administrator, Diversion Final Agency Action (RFFA), at 2 (citing ‘‘TEMPORARILY SUSPENDED’’ his
Control Division, Drug Enforcement GX 5). Specifically, a DEA Diversion ‘‘license to practice as a medical
Administration (DEA), issued an Order Investigator from that Field Division
to Show Cause to Mehdi Nikparvarfard, states that she, along with a Task Force 1 The DEA Certification of Registration Status

M.D. (Registrant), of Philadelphia, Officer, ‘‘presented the [Order] to Dr. confirms that Registrant has DATA-Waiver
Pennsylvania. The Show Cause Order Nikparvar-Fard’’ and that he ‘‘took the Authority, but it does not include the identification
number for that authority. However, I take official
proposed the revocation of Registrant’s [Order].’’ GX5, at 1. notice that the Agency’s registration records show
Certificate of Registration No. On December 21, 2018, the that Registrant’s DATA-Waiver Identification
BN8871231 on the ground that he has Government forwarded its Request for Number is XN8871231. Under the Administrative
‘‘no state authority to handle controlled Final Agency Action and an evidentiary Procedure Act (APA), an agency ‘‘may take official
notice of facts at any stage in a proceeding—even
amozie on DSK30RV082PROD with NOTICES

substances.’’ Order to Show Cause, record to my Office. Therein, the in the final decision.’’ U.S. Dept. of Justice,
Government Exhibit (GX) 2, at 1 (citing Government represents that it has not Attorney General’s Manual on the Administrative
21 U.S.C. 824(a)(3)). For the same received a hearing request and that Procedure Act 80 (1947) (Wm. W. Gaunt & Sons,
reason, the Order also proposed the Registrant ‘‘has not otherwise Inc., Reprint 1979). In accordance with the APA
and DEA’s regulations, Registrant is ‘‘entitled on
denial of any of Registrant’s corresponded or communicated with timely request to an opportunity to show to the
‘‘applications for renewal or DEA regarding the Order served on contrary.’’ 5 U.S.C. 556(e); see also 21 CFR
modification of such registration and him.’’ RFFA, at 2. Based on the 1316.59(e).

VerDate Sep<11>2014 18:12 Apr 03, 2018 Jkt 244001 PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 E:\FR\FM\04APN1.SGM 04APN1
14504 Federal Register / Vol. 83, No. 65 / Wednesday, April 4, 2018 / Notices

physician and surgeon’’ in 802(21). Second, in setting the pending application for any other
Pennsylvania. GX 3, at 1, 2. The Board requirements for obtaining a registration in the Commonwealth of
also directed Registrant to ‘‘surrender practitioner’s registration, Congress Pennsylvania, be, and it hereby is,
his wall certificate(s), biennial renewal directed that ‘‘[t]he Attorney General denied. This Order is effective
certificate(s) and wallet card(s)’’ to state shall register practitioners . . . if the immediately.3
authorities upon service of the Order. applicant is authorized to dispense . . . Dated: March 26, 2018.
Id. at 2. On October 6, 2017, the Board controlled substances under the laws of Robert W. Patterson,
issued an ‘‘Order Granting Continuance the State in which [s]he practices.’’ 21
Acting Administrator.
and Continuing Suspension’’ stating U.S.C. 823(f). Because Congress has
[FR Doc. 2018–06870 Filed 4–3–18; 8:45 am]
that Registrant had ‘‘agree[d] to toll the clearly mandated that a practitioner
BILLING CODE 4410–09–P
180-day limit for the immediate and possess state authority in order to be
temporary suspension of [his] license deemed a practitioner under the Act,
. . . and [his] license shall remain DEA has held repeatedly that revocation
DEPARTMENT OF JUSTICE
SUSPENDED until a preliminary of a practitioner’s registration is the
hearing is rescheduled or upon further appropriate sanction whenever he is no Drug Enforcement Administration
order of the State Board of Medicine.’’ longer authorized to dispense controlled
GX 4, at 1. In light of the passage of time substances under the laws of the State [Docket No. DEA–392]
since the effective date of the Order, I in which he engages in professional
have queried the Pennsylvania Medical practice. See, e.g., Calvin Ramsey, 76 FR Importer of Controlled Substances
Board’s website regarding the status of 20034, 20036 (2011); Sheran Arden Application: Catalent Pharma
Registrant’s medical license, and I take Yeates, M.D., 71 FR 39130, 39131 Solutions, LLC
official notice 2 that Registrant’s (2006); Dominick A. Ricci, 58 FR 51104, ACTION: Notice of application.
Pennsylvania medical license remains 51105 (1993); Bobby Watts, 53 FR
suspended as of the date of this 11919, 11920 (1988); Blanton, 43 FR DATES: Registered bulk manufacturers of
decision. Based on the above, I find that 27616 (1978). the affected basic classes, and
Registrant does not currently have Moreover, because ‘‘the controlling applicants therefore, may file written
authority under the laws of question’’ in a proceeding brought comments on or objections to the
Pennsylvania to dispense controlled under 21 U.S.C. 824(a)(3) is whether the issuance of the proposed registration on
substances. holder of a DEA registration ‘‘is or before May 4, 2018. Such persons
currently authorized to handle may also file a written request for a
Discussion controlled substances in the [S]tate,’’ hearing on the application on or before
Pursuant to 21 U.S.C. 824(a)(3), the Hooper, 76 FR at 71371 (quoting Anne May 4, 2018.
Attorney General is authorized to Lazar Thorn, 62 FR 12847, 12848 ADDRESSES: Written comments should
suspend or revoke a registration issued (1997)), the Agency has also long held be sent to: Drug Enforcement
under section 823 of Title 21, ‘‘upon a that revocation is warranted even where Administration, Attention: DEA Federal
finding that the registrant . . . has had a practitioner has lost his state authority Register Representative/DRW, 8701
his State license . . . suspended [or] by virtue of the State’s use of summary Morrissette Drive, Springfield, Virginia
revoked . . . by competent State process and the State has yet to provide 22152. All requests for hearing must be
authority and is no longer authorized by a hearing to challenge the suspension. sent to: Drug Enforcement
State law to engage in the . . . Bourne Pharmacy, 72 FR 18273, 18274 Administration, Attn: Administrator,
dispensing of controlled substances.’’ (2007); Wingfield Drugs, 52 FR 27070, 8701 Morrissette Drive, Springfield,
With respect to a practitioner, DEA has 27071 (1987). Thus, it is of no Virginia 22152. All requests for hearing
long held that the possession of consequence that the Pennsylvania should also be sent to: (1) Drug
authority to dispense controlled Medical Board has suspended Enforcement Administration, Attn:
substances under the laws of the State Registrant’s state license and that Hearing Clerk/LJ, 8701 Morrissette
in which a practitioner engages in Registrant may prevail in a future state Drive, Springfield, Virginia 22152; and
professional practice is a fundamental hearing. What is consequential is the (2) Drug Enforcement Administration,
condition for obtaining and maintaining fact that Registrant is not currently Attn: DEA Federal Register
a registration. See, e.g., James L. Hooper, authorized to dispense controlled Representative/DRW, 8701 Morrissette
76 FR 71371 (2011), pet. for rev. denied, substances in Pennsylvania, the State in Drive, Springfield, Virginia 22152.
481 Fed. Appx. 826 (4th Cir. 2012); see which he is registered. I will therefore
SUPPLEMENTARY INFORMATION: The
also Frederick Marsh Blanton, 43 FR revoke his DEA registration, deny any
27616 (1978) (‘‘State authorization to Attorney General has delegated his
pending application to modify his
dispense or otherwise handle controlled authority under the Controlled
registration, or any pending application
substances is a prerequisite to the Substances Act to the Administrator of
for any other registration in
the Drug Enforcement Administration
issuance and maintenance of a Federal Pennsylvania.
(DEA), 28 CFR 0.100(b). Authority to
controlled substances registration.’’).
This rule derives from the text of two Order exercise all necessary functions with
provisions of the CSA. First, Congress Pursuant to the authority vested in me respect to the promulgation and
defined ‘‘the term ‘practitioner’ [to] by 21 U.S.C. 823(f) and 824(a), as well implementation of 21 CFR part 1301,
mean[] a . . . physician . . . or other as 28 CFR 0.100(b), I order that DEA incident to the registration of
person licensed, registered or otherwise Certificate of Registration No. manufacturers, distributors, dispensers,
importers, and exporters of controlled
amozie on DSK30RV082PROD with NOTICES

permitted, by . . . the jurisdiction in BN8871231 and DATA-Waiver
which he practices . . . to distribute, Identification Number XN8871231, substances (other than final orders in
dispense, [or] administer . . . a issued to Mehdi Nikparvarfard, M.D., connection with suspension, denial, or
controlled substance in the course of be, and it hereby is, revoked. I further 3 For the same reasons that led the Pennsylvania
professional practice.’’ 21 U.S.C. order that any pending application of Board of Medicine to suspend Registrant’s license,
Mehdi Nikparvarfard to renew or I find that the public interest necessitates that this
2 See supra footnote 1. modify the above registration, or any Order be effective immediately. 21 CFR 1316.67.

VerDate Sep<11>2014 18:12 Apr 03, 2018 Jkt 244001 PO 00000 Frm 00095 Fmt 4703 Sfmt 4703 E:\FR\FM\04APN1.SGM 04APN1
Document Created: 2018-11-01 09:11:47
Document Modified: 2018-11-01 09:11:47
Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		83 FR 14503
83 FR 14503 - Mehdi Nikparvarfard, M.D.; Decision and Order

DEPARTMENT OF JUSTICEDrug Enforcement Administration

Federal Register Volume 83, Issue 65 (April 4, 2018)

DEPARTMENT OF JUSTICE
Drug Enforcement Administration
